Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU vs US: Which Medtech Launch Market Offers Best Returns?

This article was originally published in Clinica

Executive Summary

The global regulatory environment is both dynamic and fluid as different countries systems evolve to meet ever changing technological demands and to reflect experience gained. Throughout the history of the EU’s Medical Device Directives, the US has been perceived to be a tougher market to crack than the EU from the regulatory standpoint. However, this position may no longer be so clear-cut. Amanda Maxwell spoke with experienced medtech investor, Thierry Chignon, who views the US to be more attractive than it has been ever before.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT102961

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel